Literature DB >> 24604675

Comparison of urine cytology and fluorescence in situ hybridization in upper urothelial tract samples.

Jordan P Reynolds1, Jesse S Voss, Benjamin R Kipp, R Jeffrey Karnes, Aziza Nassar, Amy C Clayton, Michael R Henry, Thomas J Sebo, Jun Zhang, Kevin C Halling.   

Abstract

BACKGROUND: The cytologic diagnosis of urothelial carcinoma (UC) of the upper urothelial tract (UT) is challenging. Using the UroVysion probe set adds diagnostic value for the detection of bladder cancer in voided urine. In instrumented UT specimens, the authors encountered positive UT cytology and fluorescence in situ hybridization (FISH) cases that did not demonstrate subsequent UT carcinoma.
METHODS: The performance of cytology and FISH in the presence or absence of concomitant bladder cancer within 2 years was compared in 61 patients (112 samples) from 2003 through 2009. The mean follow-up was 3.2 years. The authors also compared the performance of near-tetrasomy versus hypertetrasomy. Biopsy confirmation of UTUC in 21 patients was considered the gold standard.
RESULTS: Cytology alone was found to be poorly sensitive (38%) but highly specific (89%) for the detection of UTUC. FISH was found to increase the sensitivity of cytology and decrease specificity. Tetrasomy FISH resulted in many false-positive cases. Other false-positive FISH results were likely due to the presence of bladder cancer cells contaminating the UT specimen.
CONCLUSIONS: Caution should be used when evaluating instrumented urine specimens of the UT from patients with a previous history of bladder carcinoma, and tetrasomy FISH results should not be interpreted as abnormal because it significantly lowers the specificity of the test. The combination of cytology and FISH appears to have good specificity while maintaining good sensitivity in evaluating UTUC when using modified scoring criteria for the appropriate patient population.
© 2014 American Cancer Society.

Entities:  

Keywords:  UroVysion; renal pelvis; ureter; ureteral washings; ureteroscopy

Mesh:

Year:  2014        PMID: 24604675     DOI: 10.1002/cncy.21414

Source DB:  PubMed          Journal:  Cancer Cytopathol        ISSN: 1934-662X            Impact factor:   5.284


  12 in total

1.  Diagnostic role of urine cytology and ureteroscopic biopsies in detection of high grade upper tract urothelial carcinoma.

Authors:  Yani Zhao; Fang-Ming Deng; Jonathan Melamed; William C Huang; Hongying Huang; Qinghu Ren
Journal:  Am J Clin Exp Urol       Date:  2021-06-15

2.  Auxiliary diagnostic value of p16 amplification combined with the detection of heterozygous and homozygous loss for urothelial carcinoma.

Authors:  Xiaopeng Mao; Baimou Li; Ying Liang; Shuhua Li; Jianwen Zhou; Qiong He; Neng Jiang; Yangshan Chen; Yu Sun; Yongmei Cui; Wenting Jiang; Han Wang; Liantang Wang; Zunfu Ke
Journal:  Oncol Lett       Date:  2018-03-01       Impact factor: 2.967

Review 3.  Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma.

Authors:  Rao S Mandalapu; Mesut Remzi; Theo M de Reijke; Vitaly Margulis; J Palou; A Kapoor; Ofer Yossepowitch; Jonathan Coleman; Olivier Traxer; J Kyle Anderson; James Catto; Jean de la Rosette; Timothy O'Brien; Anthony Zlotta; Surena F Matin
Journal:  World J Urol       Date:  2016-05-27       Impact factor: 4.226

4.  Prospective evaluation of fluorescence in situ hybridization for diagnosing urothelial carcinoma.

Authors:  Tianhai Lin; Zhenhua Liu; Liangren Liu; Lu Yang; Ping Han; Peng Zhang; Qiang Wei
Journal:  Oncol Lett       Date:  2017-03-27       Impact factor: 2.967

5.  Clinical Evaluation of Two Non-Invasive Genetic Tests for Detection and Monitoring of Urothelial Carcinoma: Validation of UroVysion and Xpert Bladder Cancer Detection Test.

Authors:  Niko Kavcic; Ivan Peric; Andreja Zagorac; Nadja Kokalj Vokac
Journal:  Front Genet       Date:  2022-06-06       Impact factor: 4.772

6.  UroVysion® predicts intravesical recurrence after radical nephroureterectomy for urothelial carcinoma of the upper urinary tract: a prospective study.

Authors:  Hidehiro Iwata; Naoto Sassa; Masashi Kato; Yota Murase; Shuko Seko; Hideji Kawanishi; Ryohei Hattori; Momokazu Gotoh; Toyonori Tsuzuki
Journal:  Int J Clin Oncol       Date:  2020-09-21       Impact factor: 3.402

7.  Prospective evaluation of FISH for detecting upper tract urothelial carcinoma in voided urine specimens.

Authors:  Qiubo Yu; Yanan Li; Gang Li; Tinghong Li; Han Zeng; Zhu Yang; Deling Wang
Journal:  Oncol Lett       Date:  2016-05-17       Impact factor: 2.967

Review 8.  Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC).

Authors:  Francesco Soria; Shahrokh F Shariat; Seth P Lerner; Hans-Martin Fritsche; Michael Rink; Wassim Kassouf; Philippe E Spiess; Yair Lotan; Dingwei Ye; Mario I Fernández; Eiji Kikuchi; Daher C Chade; Marko Babjuk; Arthur P Grollman; George N Thalmann
Journal:  World J Urol       Date:  2016-09-07       Impact factor: 4.226

Review 9.  Risk stratification for kidney sparing procedure in upper tract urothelial carcinoma.

Authors:  Zine-Eddine Khene; Romain Mathieu; Solène-Florence Kammerer-Jacquet; Thomas Seisen; Morgan Roupret; Shahrokh F Shariat; Benoit Peyronnet; Karim Bensalah
Journal:  Transl Androl Urol       Date:  2016-10

10.  Upper tract urinary cytology to detect upper tract urothelial carcinoma: Using the Johns Hopkins Hospital template and evaluation of its feasibility.

Authors:  Longwen Chen; Huiying He; Matthew A Zarka; Ming Zhou; Cristina Magi-Galluzzi
Journal:  Cytojournal       Date:  2015-07-28       Impact factor: 2.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.